Home » Topics » BioWorld Science

BioWorld Science
RSS

OraVax: Q3 1997 highlights

Nov. 25, 1997

Novartis: Q3 1997 highlights

Nov. 25, 1997

GelTex: Q3 1997 highlights

Nov. 25, 1997

GalaGen: Q3 1997 highlights

Nov. 25, 1997

Draxis Health: Q3 1997 highlights

Nov. 25, 1997

Development of new quinolone from Toyama advances

Nov. 24, 1997

Combivir recommended for approval in Europe

Nov. 24, 1997

Novartis launches once-monthly formulation of Sandostatin

Nov. 24, 1997

Gel formulation of diclofenac and hyaluronan effective in aphthous ulcer pain

Nov. 24, 1997

Antifungal activity of KP-103 under evaluation

Nov. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026